Orbital cellulitisMANAGEMENT

OPHTHALMOLOGIC PRESENTATIONS · 12 SECTIONS

⚲

428 items

☷ Legend

⚲

Cardiovascular Presentations66▾

Respiratory Presentations47▾

Neurological Presentations77▾

Gastrointestinal Presentations63▾

Genitourinary and Reproductive Presentations44▾

Infectious Disease Presentations146▾

Trauma Presentations88▾

Toxicologic Presentations67▾

Psychiatric Presentations25▾

Musculoskeletal and Rheumatologic Presentations89▾

Dermatology Presentations21▾

Environmental and Exposure Presentations26▾

Hematologic and Oncologic Presentations30▾

Pediatric-Specific Presentations13▾

Endocrine and Metabolic Presentations42▾

ENT and Maxillofacial Presentations21▾

Ophthalmologic Presentations15▾

Acute angle-closure glaucoma Central retinal artery occlusion Central Retinal Vein Occlusion Chemical eye injury Corneal abrasion Corneal ulcer Globe rupture Hyphema Iritis-Uveitis Ocular foreign body Optic Neuritis Orbital cellulitis Orbital Floor Fracture (Blowout)Retinal detachment Vitreous Hemorrhage

Obstetric Presentations17▾

Systemic and Miscellaneous Presentations15▾

01Approach to the Critical Patient/attcp49

Time-critical priorities

›Immediate stabilization

›Airway compromise

›If stridor

›If inability to handle secretions

›Sepsis physiology

›If hypotension

›If altered mental status

›Vision-threatening findings

›If decreased visual acuity

›If afferent pupillary defect

›Intracranial extension concern

›If severe headache

›If meningismus

Immediate consultations

›Specialist activation

›Ophthalmology emergent

›If any orbital signs

›If any visual deficit

›ENT emergent

›If sinusitis source suspected

›If abscess on imaging

›Infectious diseases

›If immunocompromised host

›If unusual organism risk

Monitoring and goals

›Targets and monitoring

›Visual acuity trending

›Baseline at presentation

›Recheck after therapy changes

›Pupils and color vision trending

›Afferent pupillary defect checks

›Red desaturation checks

›Extraocular movements trending

›Pain with movement

›Ophthalmoplegia

›Vital sign trending

›Fever curve

›Hemodynamic stability

Key concepts

›Bedside distinctions

›Orbital cellulitis definition

›Infection posterior to orbital septum

›Risk of optic neuropathy

›Preseptal cellulitis definition

›Infection anterior to orbital septum

›No proptosis

›Primary source patterns

›Acute bacterial rhinosinusitis most common

›Dental source possible

›Evidence framing

›Class I recommendation for urgent ophthalmology evaluation in suspected orbital cellulitis

›Class I recommendation for IV antibiotics without delay when orbital cellulitis suspected

02History/hx36

Presentation pattern

›Symptom cluster

›Eyelid swelling and erythema

›Rapid progression over hours to days

›Unilateral predominance

›Orbital pain

›Pain with eye movement

›Deep ache

›Visual symptoms

›Blurred vision

›Diplopia

›Systemic symptoms

›Fever

›Malaise

Risk factors and sources

›Predisposing context

›Sinusitis history

›Recent URI

›Facial pressure

›Trauma history

›Periorbital laceration

›Insect bite

›Dental infection

›Tooth pain

›Recent dental procedure

›Immunocompromised state

›Diabetes mellitus

›Neutropenia

Medication and allergy context

›Treatment modifiers

›Antibiotic exposure

›Prior beta lactam use

›MRSA-active agent exposure

›Allergy history

›Immediate beta lactam reaction

›Severe cutaneous adverse reaction

›Contact lens use

›Corneal risk overlap

›Pseudomonas risk overlap

03Physical Exam/exam39

Eye and orbit focused

›Orbital findings

›Visual acuity

›Any reduction from baseline

›Poor cooperation strategy

›Pupils

›Relative afferent pupillary defect

›Anisocoria

›Extraocular movements

›Pain with movement

›Ophthalmoplegia

›Proptosis

›Globe displacement

›Lid closure difficulty

›Chemosis

›Conjunctival edema

›Exposure keratopathy risk

Head and neck focused

›Source and extension exam

›Sinus tenderness

›Maxillary

›Ethmoid

›Nasal exam

›Purulence

›Septal deviation

›Dental exam

›Gingival swelling

›Tooth percussion tenderness

›Neurologic exam

›Mental status

›Cranial nerves III, IV, V1, V2, VI

PITFALLS

›High-risk misses

›Normal temperature

›Early disease possibility

›Antipyretic masking

›Minimal eyelid erythema

›Deep orbital process possible

›Immunocompromised blunting

›Incomplete eye exam

›Unrecognized optic neuropathy risk

›Sedation need in pediatrics

04Differential Diagnosis/ddx39

Immediate threats and mimics

›Competing diagnoses

›Preseptal cellulitis

›No proptosis

›No pain with EOM

›Subperiosteal abscess

›Proptosis

›Restricted EOM

›Orbital abscess

›Severe proptosis

›Vision loss risk

›Cavernous sinus thrombosis

›Cranial nerve palsies

›Bilateral ocular findings

›Endophthalmitis

›Hypopyon

›Severe pain with vision loss

Noninfectious mimics

›Alternative etiologies

›Allergic angioedema

›Itching

›Rapid bilateral swelling

›Thyroid eye disease

›Chronic progression

›Lid retraction

›Idiopathic orbital inflammation

›Steroid responsiveness

›Imaging without sinusitis

›Herpes zoster ophthalmicus

›Dermatomal vesicles

›Hutchinson sign

Coding alignment

›Medical coding anchors

›ICD-10 H05.0 orbital cellulitis

›Use for postseptal infection

›Pair with sinusitis code when present

›ICD-10 L03.213 cellulitis of right periorbital region

›Use for preseptal cellulitis when appropriate

›Laterality specific options

›SNOMED CT concept mapping

›Orbital cellulitis disorder

›Periorbital cellulitis disorder

05Laboratory Tests/lt27

Core tests

›Initial labs

›Complete blood count for systemic infection

›Leukocytosis support

›Neutropenia risk stratification

›C-reactive protein for severity trend

›Baseline for trajectory

›Rising trend suggests progression

›Basic metabolic panel for IV therapy safety

›Creatinine for vancomycin dosing

›Electrolytes for sepsis care

Microbiology

›Culture strategy

›Blood cultures for febrile or toxic appearance

›Higher yield in pediatric bacteremia

›Draw before antibiotics if feasible

›Nasal MRSA screening support

›Negative predictive value context dependent

›Not a rule-out test

›Sinus or abscess culture if drained

›Guides de-escalation

›Anaerobe identification

Sepsis adjuncts

›Severity adjuncts

›Lactate for suspected sepsis

›mmol/L reporting

›Trend with resuscitation

›Venous blood gas if respiratory concern

›pCO2 in mmHg

›Acid base context

06Diagnostic Tests/dt43

Scoring Systems

›Classification and risk tools

›Chandler classification for orbital complications of sinusitis

›Group 1 preseptal cellulitis

›Group 2 orbital cellulitis

›Group 3 subperiosteal abscess

›Group 4 orbital abscess

›Group 5 cavernous sinus thrombosis

›Pediatric sepsis screening framework

›Abnormal perfusion

›Altered mental status

MRI

›MRI considerations

›Indications

›Intracranial extension concern

›Cavernous sinus thrombosis concern

›Protocol pearls

›Orbit and brain with contrast

›MR venography if cavernous sinus thrombosis concern

›Limitations

›Availability delays

›Sedation need in pediatrics

›CT orbit and sinuses with IV contrast

›Indications

›Suspected orbital cellulitis

›Suspected abscess

›What CT answers

›Subperiosteal abscess presence

›Orbital abscess presence

›Interpretation flags

›Extraocular muscle enlargement

›Postseptal fat stranding

›Evidence framing

›ACEP Level B style recommendation for CT when orbital cellulitis suspected and exam suggests postseptal involvement

›Class I recommendation for imaging when any orbital signs present

Ultrasound

›Ultrasound role

›Bedside adjunct

›Orbital fluid collection screening

›Proptosis estimation support

›Limitations

›Cannot exclude postseptal infection

›Operator dependent

›Safety notes

›Avoid pressure on globe if globe rupture concern

›Avoid in severe pain limiting exam

07Disposition/dispo30

Level of care

›Admission pathway

›Inpatient admission default

›Orbital cellulitis diagnosis

›Need for IV antibiotics

›ICU triggers

›Hemodynamic instability

›Altered mental status

›Transfer triggers

›No ophthalmology availability

›No ENT surgical capability

Criteria linked to discharge timing

›Step-down to oral therapy

›Clinical improvement window

›Afebrile trend

›Reduced proptosis and EOM pain

›Vision stability

›Visual acuity stable or improved

›No new pupillary abnormality

›Reliable follow-up

›Ophthalmology follow-up arranged

›ENT follow-up if sinus source

Surgical disposition triggers

›Operative decision points

›Subperiosteal abscess

›Large size on imaging

›Vision compromise

›Orbital abscess

›Any confirmed abscess with clinical decline

›Failure of IV antibiotics

›Intracranial extension

›Neurosurgery involvement

›Broad-spectrum escalation

08Treatment/t69

Supportive care

›Adjunctive measures

›Analgesia strategy

›Acetaminophen dosing per weight

›Opioid sparing options

›Eye surface protection

›Lubricating ointment if exposure

›Moisture chamber if incomplete lid closure

›Glycemic control

›Hyperglycemia management in diabetics

›DKA screening if symptomatic

Empiric IV antibiotics

›Adult empiric regimens

›First-line broad coverage

›Ampicillin-sulbactam IV 3 g every 6 hours

›Spectrum includes streptococci

›Spectrum includes MSSA

›Spectrum includes anaerobes

›If MRSA risk add vancomycin IV 15 to 20 mg/kg every 8 to 12 hours

›Target trough per local protocol

›Renal dosing adjustment

›Alternative broad coverage

›Ceftriaxone IV 2 g every 24 hours

›Add metronidazole IV 500 mg every 8 hours for anaerobes

›Add vancomycin IV 15 to 20 mg/kg every 8 to 12 hours for MRSA risk

›Severe infection or intracranial extension concern

›Piperacillin-tazobactam IV 4.5 g every 6 hours

›Add vancomycin IV 15 to 20 mg/kg every 8 to 12 hours

›Broader gram negative coverage

Pediatric empiric IV antibiotics

›Pediatric empiric regimens

›Weight-based broad coverage

›Ampicillin-sulbactam IV 50 mg/kg per dose as ampicillin every 6 hours

›Maximum 2 g ampicillin per dose

›Sinusitis source coverage

›If MRSA risk add vancomycin IV 15 mg/kg per dose every 6 hours

›Target trough per local protocol

›Renal dosing adjustment

›Beta lactam allergy strategy

›Clindamycin IV 10 mg/kg per dose every 8 hours

›Maximum 900 mg per dose

›MRSA and anaerobe coverage

›Add ceftriaxone alternative only if non-anaphylactic allergy

›Ceftriaxone IV 50 mg/kg every 24 hours

›Maximum 2 g daily

Antifungal and atypical coverage

›Expanded coverage triggers

›Suspected mucormycosis

›DKA

›Immunosuppression

›Amphotericin B initiation in high suspicion cases

›Liposomal amphotericin dosing per specialist protocol

›Immediate ENT and ophthalmology co-management

›Odontogenic source expansion

›Anaerobe coverage ensured

›Dental or OMFS involvement

Steroids and adjuncts

›Anti-inflammatory adjuncts

›Systemic corticosteroids

›Consider only after antibiotics started

›Specialist-guided timing

›Nasal therapies for sinus source

›Saline irrigation

›Intranasal corticosteroid per ENT plan

Surgical management

›Drainage pathways

›Endoscopic sinus surgery indications

›Abscess on imaging

›Failure to improve within 24 to 48 hours

›Orbit decompression or drainage indications

›Vision compromise

›Orbital abscess

›Evidence framing

›Class I recommendation for surgical drainage when vision threatened

›Class IIa recommendation for drainage in failure of medical therapy

09Special Populations/sp30

Pregnancy

›Pregnancy considerations

›Imaging selection

›MRI preferred when feasible for intracranial extension

›CT acceptable when vision threatened

›Antibiotic safety

›Beta lactams generally preferred

›Vancomycin acceptable when indicated

›Obstetric coordination

›Fetal monitoring in viable gestation if critically ill

›Maternal stabilization priority

Geriatric

›Geriatric considerations

›Higher complication risk

›Diabetes prevalence

›Atypical fever response

›Medication safety

›Renal dosing adjustments

›Polypharmacy interaction review

›Mimic overlap

›Temporal arteritis consideration with vision symptoms

›Malignancy masquerade with chronic course

Pediatrics

›Pediatric considerations

›Ethmoid sinus predominance

›Medial orbital involvement

›Subperiosteal abscess risk

›Exam challenges

›Limited cooperation

›Sedation need for imaging

›Admission default

›IV therapy requirement

›Rapid progression risk

10Background/b31

Epidemiology

›Epidemiology facts

›Common source pattern

›Acute bacterial sinusitis linkage

›Ethmoid sinus prominence in children

›Typical microbiology

›Streptococcus species

›Staphylococcus aureus

›Resistance considerations

›Community MRSA prevalence varies by region

›Prior antibiotic exposure increases resistant risk

Pathophysiology

›Mechanisms

›Septum anatomy

›Orbital septum barrier concept

›Postseptal space risk for optic nerve involvement

›Spread pathways

›Sinus to orbit via lamina papyracea

›Venous spread to cavernous sinus

›Complications

›Optic neuropathy from pressure and inflammation

›Intracranial extension via venous channels

Therapeutic Considerations

›Treatment rationale

›Early IV antibiotics importance

›Prevent abscess formation

›Reduce vision loss risk

›Coverage goals

›Streptococci coverage

›Staphylococci coverage

›Anaerobe coverage when sinus or dental source

›Evidence framing

›Class I recommendation for broad-spectrum IV antibiotics at presentation

›Class IIb recommendation for adjunct corticosteroids only in select cases after antibiotics

11Patient Discharge Instructions/pdi18

copy discharge instructions

›Post-hospital instructions

›Antibiotic adherence

›Complete full course as prescribed

›Do not stop early if improved

›Eye care

›Lubrication if dryness or incomplete closure

›Avoid contact lenses until cleared

›Follow-up plan

›Ophthalmology appointment date and time

›ENT appointment if sinus source

›Return immediately for red flags

›Any vision change

›New double vision

›Increasing eye pain

›Worsening swelling or proptosis

›Fever recurrence

›Severe headache

›Confusion or neck stiffness

12References/r17

Guidelines and high-yield sources

›Professional guidance

›Ophthalmology practice resources on orbital cellulitis evaluation and management

›Emergent ophthalmology involvement emphasis

›Vision monitoring emphasis

›Pediatric sinusitis and orbital complication pathways

›Admission and IV antibiotics default

›Surgical drainage criteria

›Antimicrobial stewardship references for sinus-related orbital infections

›MRSA risk based escalation

›Anaerobe coverage for dental sources

Evidence summaries

›Evidence and consensus framing

›Class I recommendation statements

›Imaging and IV antibiotics when orbital signs present

›Drainage when vision threatened

›ACEP Level A/B/C style labeling where applicable

›Level B style support for CT in suspected postseptal disease

›Level C style consensus for ultrasound as adjunct only

Learn More: Orbital cellulitis→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed June 16, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.